Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study

NCT02691455 is registered in ClinicalTrials.gov with Robert Feldman as lead sponsor.

NCT NCT02691455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02691455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study
Lead sponsor
Robert Feldman
Phase
Not applicable
Overall status
Terminated
Start date
February 29, 2016
Completion date
September 30, 2020
Enrollment
50 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma